Article

Synthetic protein antigens for COVID-19 diagnostics

2021-03-01

Abstract excerpt

There is an urgent need for inexpensive, rapid and specific antigen-based assays to test for infection with SARS-CoV-2 and distinguish variants arising as the COVID-19 pandemic spreads. We have identified a small, synthetic protein (JS7), representing a region of maximum variability within the receptor binding domain (RBD), which binds antibodies in sera from nine patients with PCR-verified COVID-19 of varying sev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7b113e74-4ed4-55d9-957a-e54bf0f7eff4
DOI: 10.1101/2021.02.23.21251934

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Synthetic protein antigens for COVID-19 diagnosticsDOI 10.1101/2021.02.23.21251934Read

Computational and Experimental Antibody Affinity and Diagnostic Accuracy Quantification of SARS-CoV-2 SD2 Major Disulfide Loop AnalogSemantic proximity Read

Peptide Antidotes to SARS-CoV-2 (COVID-19)Semantic proximity Read

Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive VaccinesSemantic proximity Read

Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics ApproachSemantic proximity Read

Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccinesSemantic proximity Read

The Devil in its Details: Unravelling the Epitopes in COVID-19 Surface Glycoprotein with the potential for Vaccination and Antibody SynthesisSemantic proximity Read

Immunogenic Amino Acid Motifs and Linear Epitopes of COVID-19 mRNA VaccinesSemantic proximity Read

In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Semantic proximity Read

In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Semantic proximity Read

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceSemantic proximity Read

A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infectionSemantic proximity Read

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutantsSemantic proximity Read